Merck

PharmaDiagnostics names director

Friday, March 11, 2011 11:39 AM

PharmaDiagnostics has appointed Dr. Sylviane Boucharens director of assay development. She joins from Merck’s MSD site in Newhouse, Scotland, where she was head of global compound repository and in vitro screening.

More... »

Merck fails to win FDA support

Tuesday, March 8, 2011 10:43 AM

Merck, based in Darmstadt, Germany, failed to win FDA support for its multiple sclerosis pill cladribine.

More... »

Merck rejects Organon deal

Monday, March 7, 2011 01:58 PM

Merck told a Dutch court it had to turn down an offer for Organon because it would have cost the company $700 million more than shuttering the operation, according to FierceBiotech.

More... »

Lycera partners with Merck

Thursday, March 3, 2011 03:17 PM

Plymouth, Mich.-based Lycera will receive $12 million upfront and up to $295 million in milestone payments from Merck in a collaboration to discover new anti-inflammatory drugs, according to FierceBiotech. The deal is focused on new small molecules that target T-helper 17 (Th17) cells, key mediators of inflammation and a new approach to treating major autoimmune diseases such as rheumatoid arthritis, psoriasis, inflammatory bowel disease and multiple sclerosis.

More... »

Fujifilm moves into biologics with Merck buy

Tuesday, March 1, 2011 01:15 PM

Japan's Fujifilm is expanding its drug business in a deal to buy two of Merck's contract manufacturing facilities, according to Fierce Pharma.

More... »

ProPublica report: big pharma paid hundreds of physicians over $100,000 in speaking fees

Monday, November 8, 2010 11:12 AM

Several doctors paid to speak on behalf of big pharmaceutical companies aren’t, in fact, the thought leaders consumers often consider them to be, but instead have been sanctioned for various forms of misconduct. And psychiatrists collect more in speaking and consulting fees from pharma companies than doctors in any other specialty.

More... »

Merck partners with Alectos to develop new type of Alzheimer’s treatment

Monday, August 23, 2010 08:00 AM

Merck has launched a research partnership with Alectos Therapeutics, a Vancouver-based biopharmaceutical company, to develop drugs to fight Alzheimer’s Disease based on an enzyme believed to be involved in the development of the disease and potentially other disorders.

More... »

Merck Launches Oncology Network, Reduces Sites

Thursday, June 17, 2010 09:14 AM

In an effort to streamline its cancer research, Merck has launched the Merck Oncology Collaborative Trials Network, a collection of key oncology-focused investigative sites around the world with which Merck will work exclusively on promising compounds during early phases.

More... »

Clinical Trial Activity in Russia Dipped in 2009

Friday, March 5, 2010 06:56 AM

According to Russia-based contract research organization (CRO) Synergy Research Group’s Annual Orange Report, Russia’s regulatory agency Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (RosZdravNadzor, RZN) approved 577 new clinical trials during 2009, 6% fewer than in 2008. Sixty percent, or 348 of the new studies, were multinational multi-center trials, down 4% from 2008.

More... »

Merck Serono Building Global R&D Center in Beijing

Thursday, December 10, 2009 07:49 AM

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, wants to strengthen its global research and development (R&D) capabilities by establishing a global R&D center in Beijing, China.

More... »